Your browser doesn't support javascript.
loading
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia.
Bushinsky, David A; Williams, Gordon H; Pitt, Bertram; Weir, Matthew R; Freeman, Mason W; Garza, Dahlia; Stasiv, Yuri; Li, Elizabeth; Berman, Lance; Bakris, George L.
Affiliation
  • Bushinsky DA; Division of Nephrology, University of Rochester School of Medicine, Rochester, New York, USA.
  • Williams GH; Department of Medicine - Endocrinology, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
  • Pitt B; University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Weir MR; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Freeman MW; Department of Medicine, Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA.
  • Garza D; Relypsa, Redwood City, California, USA.
  • Stasiv Y; Relypsa, Redwood City, California, USA.
  • Li E; PharmaStat, Newark, California, USA.
  • Berman L; Relypsa, Redwood City, California, USA.
  • Bakris GL; Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, Illinois, USA.
Kidney Int ; 88(6): 1427-1433, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26376130
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2015 Type: Article